Name: Respiratory Syncytial Virus (RSV) Vaccine
SKU: 670f6c1f48999c000e1e4e47
Price: 2600.0 HKD
Availability: InStock

Your Shopping Cart is empty.

${{ (item.variation.media ? item.variation.media.alt_translations : item.product.cover_media.alt_translations) | translateModel }}$ ${{ (item.variation.media ? item.variation.media.alt_translations : item.product.cover_media.alt_translations) | translateModel }}$

{{ childProduct.title_translations | translateModel }}

{{ getChildVariationShorthand(childProduct.child_variation) }}

{{ getSelectedItemDetail(selectedChildProduct, item).childProductName }} x {{ selectedChildProduct.quantity || 1 }}

{{ getSelectedItemDetail(selectedChildProduct, item).childVariationName }}

{{item.quantity}}x HK$0 {{ item.unit_point }} Point

Remove

${{addonItem.product.cover_media.alt_translations | translateModel}}$

{{addonItem.quantity}}x {{ mainConfig.merchantData.base_currency.alternate_symbol + "0" }}

Remove

Respiratory Syncytial Virus (RSV) Vaccine

Respiratory syncytial virus (RSV) is a common respiratory virus that usually causes mild, cold-like symptoms.

Vaccines by Doctor / Nurse only

HK$2,600.00

{{shoplineProductReview.avg_score}} {{'product.product_review.stars' | translate}} | {{shoplineProductReview.total}} {{'product.product_review.reviews' | translate}}

{{amazonProductReview.avg_rating}} {{'product.product_review.stars' | translate}} | {{amazonProductReview.total_comment_count}} {{'product.product_review.reviews' | translate}}

The maximum quantity per submit is 99999

This quantity is invalid, please enter a valid quantity.

Sold Out

Please message the shop owner for order details.

Description

Items

Vaccine : Respiratory Syncytial Virus (RSV) Vaccine

Manufacturer : GSK

Doses in Routine : Series1 Dose

Who Should Get RSV Vaccination?

Recommendations for individuals aged 60 and above, especially those with chronic illnesses, to receive early vaccination.

Incubation period

The incubation period is 1 – 10 days, usually 5 – 7 days.

RSV Vaccine

RSV is a common virus that can cause serious respiratory illness, especially in infants and older adults.

The RSV vaccine has been shown to have a protective efficacy of approximately 82.6% to 94.6%. This is an impressively high level of protection, which would create a strong immune barrier, especially for high-risk populations like infants and the elderly.

Shipping & Payment